Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the design of drugs targeting central nervous system disorders and inflammatory diseases. The difluoroazetidine and piperidine moieties enhance metabolic stability and binding affinity, making it valuable in medicinal chemistry for optimizing drug candidates. Commonly employed in research settings for structure-activity relationship (SAR) studies.